Company intelligence / Profile preview

M3 Wake Research

Raleigh, North Carolina, United Stateswakeresearch.com ↗

Ownership: Private
Employees: ~145
Development stage: Commercial

Overview

M3 Wake Research has completed over 9,100 clinical trials, supporting hundreds of pharmaceutical and biotech sponsors and CROs. They are recognized for rapid trial start-up and high-quality data collection across diverse therapeutic areas. No proprietary drugs or direct clinical results as they are a service provider.

Therapeutic areas: GastroenterologyRheumatologyEndocrinologyImmunologyDermatologyOtherWomen's HealthNeurologyInfectious Diseases
Modalities: Small moleculeBiologicVaccineMedical device
Industry: Contract Research Organization

Partnerships

Hundreds of pharmaceutical and biotech sponsors and CROs; specific names not disclosed publicly

Beyond the preview

Go deeper on M3 Wake Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on M3 Wake Research.

Explore the full profile